Selection of carrier and B cell protectope sequences for vaccines.
Etlinger
H M
HM
F. Hoffmann-La Roche & Company, Basel, Switzerland.
D000276:Adjuvants, Immunologic; D000595:Amino Acid Sequence; D000818:Animals; D000938:Antigen-Presenting Cells / Q000276:immunology; D000953:Antigens, Protozoan / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology*; D004167:Diphtheria Toxin / Q000276:immunology; D006801:Humans; D007156:Immunologic Memory; D017780:Malaria Vaccines / Q000276:immunology*; D051379:Mice; D008969:Molecular Sequence Data; D010455:Peptides / Q000276:immunology*; D010456:Peptides, Cyclic / Q000276:immunology; D010961:Plasmodium / Q000276:immunology; D011487:Protein Conformation; D015800:Protozoan Proteins / Q000276:immunology; D011993:Recombinant Fusion Proteins / Q000276:immunology; D013745:Tetanus Toxoid / Q000276:immunology; D017778:Vaccines, Combined / Q000276:immunology
D000276:Adjuvants, Immunologic; D000953:Antigens, Protozoan; D004167:Diphtheria Toxin; D017780:Malaria Vaccines; D010455:Peptides; D010456:Peptides, Cyclic; D015800:Protozoan Proteins; D011993:Recombinant Fusion Proteins; D013745:Tetanus Toxoid; D017778:Vaccines, Combined; C041595:circumsporozoite protein, Protozoan; C065974:merozoite surface protein 2, Plasmodium